Amlodipine for African American Patients with Hypertension
Yes, amlodipine is an excellent first-line choice for African American patients with hypertension and is specifically recommended by the 2017 ACC/AHA guidelines as initial therapy. 1
Guideline-Based Recommendations
The 2017 ACC/AHA hypertension guidelines provide a Class I, Level B-R recommendation that in Black adults with hypertension but without heart failure or chronic kidney disease (including those with diabetes), initial antihypertensive treatment should include either a thiazide-type diuretic or a calcium channel blocker (CCB) like amlodipine. 1
Key Evidence Supporting Amlodipine Use
Amlodipine demonstrates equivalent or superior efficacy compared to thiazide diuretics in African American patients:
Amlodipine is as effective as chlorthalidone (the gold-standard thiazide) and more effective than the ACE inhibitor lisinopril in reducing blood pressure, cardiovascular disease events, and stroke in Black patients. 1
The only area where amlodipine shows slightly less benefit than chlorthalidone is in preventing heart failure, though this does not negate its overall cardiovascular protective effects. 1
Recent trial data from sub-Saharan Africa confirms superior efficacy:
The CREOLE trial (2019) demonstrated that amlodipine-based dual therapy (either with hydrochlorothiazide or perindopril) achieved significantly greater 24-hour ambulatory blood pressure reductions than non-amlodipine combinations in Black African patients. 2
Specifically, amlodipine plus hydrochlorothiazide reduced systolic BP by an additional 3.14 mmHg compared to perindopril plus hydrochlorothiazide (P=0.03). 2
Clinical Advantages in African American Patients
Amlodipine offers several practical benefits in this population:
Superior BP lowering as monotherapy: CCBs like amlodipine are more effective than RAS inhibitors (ACE inhibitors, ARBs) or beta blockers when used as single agents in Black patients. 1
Long duration of action: Amlodipine's 35-50 hour half-life provides sustained BP control over 24 hours and maintains protection even if a dose is missed—important for real-world adherence. 3
Reduced stroke risk: Amlodipine provides particularly strong stroke prevention, which is critical given the higher stroke burden in African Americans. 1
No metabolic concerns: Unlike thiazides, amlodipine does not worsen glycemic control or kidney function in patients with diabetes or chronic kidney disease. 3
Combination Therapy Considerations
Most African American patients require two or more antihypertensive medications (Class I, Level C-LD recommendation) to achieve BP targets of <130/80 mmHg. 1
Optimal combinations include:
Amlodipine + thiazide diuretic: Single-tablet combinations are particularly effective in achieving BP control in Black patients. 1
Amlodipine + ACE inhibitor or ARB: Produces similar BP lowering in Black patients as in other racial groups when used in combination (though less effective as monotherapy). 1
Important caveat: While ACE inhibitors are less effective as monotherapy in Black patients without compelling indications, they should still be included in multidrug regimens for those with chronic kidney disease or heart failure. 1 Black patients also have a greater risk of angioedema with ACE inhibitors. 1
Safety Profile
Amlodipine is well-tolerated in African American patients with adverse event rates comparable to other populations. 4, 5 Common side effects include peripheral edema (7-9%), headache, fatigue, and flushing, which are more frequent with the 10 mg dose. 6, 3